2021
2021
In 2021, we completed our first global Scope 1 and 2 GHG inventory
Innovating Sustainably
At BeOne, our commitment to reducing environmental impact is directly aligned with our mission to improve health and increase access around the world. We recognize that environmental disruptions may affect our ability to deliver essential therapies to patients, and our reliance on specific natural resources, such as clean water, underscores the need for sustainable practices. By working to minimize our impact while fostering resilience against future disruptions, we will be in a stronger position to provide life-saving medications globally and we can safeguard the long-term, sustainable growth of our organization.
2022
2022
In 2022, we completed a climate risk assessment in alignment with the Taskforce on Climate-related Financial Disclosures (TCFD). We also completed our first Scope 3 GHG inventory
2023
2023
In 2023, we announced our first quantitative climate goal to reduce our Scope 1 and 2 emissions, (emissions generated by owned and operated facilities), by 25% per unit of internally manufactured commercial product by 2026 from a 2021 base year.
2024
2024
In 2024, we conducted a nature-related preparedness assessment based on the Taskforce for Nature Related Financial Disclosures (TNFD) and the Science Based Targets Network (SBTN) frameworks. We also published a formal Product Stewardship Statement.
2021
2022
2023
2024